• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17977

【品名】1-Fluoro-4-isocyanatobenzene; 4-Fluorophenyl isocyanate

【CA登记号】1195-45-5

【 分 子 式 】C7H4FNO

【 分 子 量 】137.1133032

【元素组成】C 61.32% H 2.94% F 13.86% N 10.22% O 11.67%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(XIII)

2-nitroaniline (III) was prepared by reaction of an excess of cyclohexylamine (II) with either 2-chloronitrobenzene (Ia) in the presence of CuI and K2CO3 at 150 C or 2-fluoronitrobenzene (Ib) in chloroform. Catalytic hydrogenation gave phenylenediamine (IV), which was selectively alkylated on the primary N atom with bromoacetylpyrrolidine (V) in the presence of K2CO3 in DMF. Condensation of the resulting (VI) with the malonic acid dichloride (VII) yielded benzodiazepine (VIII). Hydrazone function was then reduced with zinc dust in acetic acid to provide amine (IX). Separation of the racemic mixture was performed by treatment with the chiral carbonic acid derivative (X), followed by chromatographic separation to give the desired (S)-isomer (XI). Cleavage of the carbamate group of (XI) was effected by hydrogenolysis to afford chiral amine (XII). The target urea was then prepared by reaction of (XII) with 4-fluorophenylisocyanate (XIII) in dichloromethane.

1 Bailey, N.; et al.; Novel 1,5-benzodiazepindione gastrin/CCKB antagonists. Bioorg Med Chem Lett 1997, 7, 3, 281.
2 Finch, H.; Shah, P.; Carr, R.A.E. (Glaxo Wellcome plc); 1,5-Benzodiazepine derivs. having CCK and/or gastrin antagonistic activity. US 5585376; US 5646140; WO 9424149; WO 9424151 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Ia) 17964 (2-chlorophenyl)(oxo)-lambda(5)-azanolate C6H5ClNO2 详情 详情
(Ib) 17965 (2-fluorophenyl)(oxo)-lambda(5)-azanolate C6H5FNO2 详情 详情
(II) 17966 cyclohexanamine; cyclohexyl amine; cyclohexylamine 108-91-8 C6H13N 详情 详情
(III) 17967 [2-(cyclohexylamino)phenyl](oxo)-lambda(5)-azanolate C12H17N2O2 详情 详情
(IV) 17968 N-(2-aminophenyl)-N-cyclohexylamine; N(1)-cyclohexyl-1,2-benzenediamine C12H18N2 详情 详情
(V) 17969 2-bromo-1-(1-pyrrolidinyl)-1-ethanone C6H10BrNO 详情 详情
(VI) 17970 2-[2-(cyclohexylamino)anilino]-1-(1-pyrrolidinyl)-1-ethanone C18H27N3O 详情 详情
(VII) 17971 2-(2-phenylhydrazono)malonoyl dichloride C9H6Cl2N2O2 详情 详情
(VIII) 17972 1-cyclohexyl-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-1,5-benzodiazepine-2,3,4(5H)-trione 3-(N-phenylhydrazone) C27H31N5O3 详情 详情
(IX) 17973 3-amino-1-cyclohexyl-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-1,5-benzodiazepine-2,4(3H,5H)-dione C21H28N4O3 详情 详情
(X) 17974 4-nitrophenyl (1S)-1-phenylethyl carbonate C15H13NO5 详情 详情
(XI) 17975 (1S)-1-phenylethyl (3R)-1-cyclohexyl-2,4-dioxo-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-ylcarbamate C30H36N4O5 详情 详情
(XII) 17976 (3R)-3-amino-1-cyclohexyl-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-1,5-benzodiazepine-2,4(3H,5H)-dione C21H28N4O3 详情 详情
(XIII) 17977 1-Fluoro-4-isocyanatobenzene; 4-Fluorophenyl isocyanate 1195-45-5 C7H4FNO 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XI)

The N-protection of 4-(2-aminoethyl)phenol (I) with benzyl chloroformate gives the N-benzyloxycarbonyl derivative (II), which is condensed with 1-methyl-1-(trichloromethyl)ethanol (III) by means of NaOH in acetone yielding the phenoxyisobutyric acid (IV). The deprotection of the amino group of (IV) by hydrogenation over Pd/C affords the ethylamino derivative (V), which is reprotected with 9-fluorenylmethoxycarbonyl protecting group to provide carbamate (VI). The acid group of (VI) is then coupled to a Sasrin polystyrene resin giving the N-protected resin (VII), which is deprotected with piperidine affording resin (VIII) with a free amino group, which is condensed with heptanoic acid (A) by means of DIC and HOBT to give the amide (IX). The reduction of the carbonyl group amide (IX) with BH3/THF yields the heptylamine (X), which is condensed with 4-fluorophenyl isocyanate (XI) to afford the urea (XII). Finally, this compound is treated with trifluoroacetic acid to eliminate the polystyrene resin and isolate the target compound. Alternatively, the heptylamine (X) can also be obtained directly by reductocondensation of the free amino group of the resin (VIII) with heptanal (B) by means of NaBH3CN.

1 Brown, P.J.; et al.; Generation of secondary alkyl amines on solid support by borane reduction. Application to the parallel synthesis of PPAR ligands. Synthesis 1997, 7, 778.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
13580 1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate 1885-14-9 C7H5ClO2 详情 详情
(B) 25714 octanal 124-13-0 C8H16O 详情 详情
(A) 35032 heptanoic acid 111-14-8 C7H14O2 详情 详情
(I) 19988 4-(2-Aminoethyl)phenol; Tyramine 51-67-2 C8H11NO 详情 详情
(II) 25974 benzyl 4-hydroxyphenethylcarbamate C16H17NO3 详情 详情
(III) 25975 1,1,1-trichloro-2-methyl-2-propanol 57-15-8 C4H7Cl3O 详情 详情
(IV) 25976 2-[4-(2-[[(benzyloxy)carbonyl]amino]ethyl)phenoxy]-2-methylpropionic acid C20H23NO5 详情 详情
(V) 25977 2-[4-(2-aminoethyl)phenoxy]-2-methylpropionic acid C12H17NO3 详情 详情
(VI) 25978 2-[4-(2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl)phenoxy]-2-methylpropionic acid C27H27NO5 详情 详情
(VII) 25978 2-[4-(2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl)phenoxy]-2-methylpropionic acid C27H27NO5 详情 详情
(VIII) 25977 2-[4-(2-aminoethyl)phenoxy]-2-methylpropionic acid C12H17NO3 详情 详情
(IX) 25979 2-[4-[2-(heptanoylamino)ethyl]phenoxy]-2-methylpropionic acid C19H29NO4 详情 详情
(X) 25980 2-[4-[2-(heptylamino)ethyl]phenoxy]-2-methylpropionic acid C19H31NO3 详情 详情
(XI) 17977 1-Fluoro-4-isocyanatobenzene; 4-Fluorophenyl isocyanate 1195-45-5 C7H4FNO 详情 详情
(XII) 25981 2-(4-[2-[[(4-fluoroanilino)carbonyl](heptyl)amino]ethyl]phenoxy)-2-methylpropionic acid C26H35FN2O4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XI)

The condensation of ethyl 2-[4-[2-(heptylamino)ethyl]phenoxy]-2-methylpropionate (XIII) with 4-fluorophenyl isocyanate (XI) gives the corresponding ureido compound (XIV), which is then hydrolyzed with NaOH in refluxing ethanol.

1 Brown, P.J.; et al.; Generation of secondary alkyl amines on solid support by borane reduction. Application to the parallel synthesis of PPAR ligands. Synthesis 1997, 7, 778.
2 Willson, T.M. (Glaxo Group Ltd.); Use of agonists of the peroxisome proliferator activated receptor alpha for treating obesity. WO 9736579 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 17977 1-Fluoro-4-isocyanatobenzene; 4-Fluorophenyl isocyanate 1195-45-5 C7H4FNO 详情 详情
(XIII) 25982 ethyl 2-[4-[2-(heptylamino)ethyl]phenoxy]-2-methylpropanoate C21H35NO3 详情 详情
(XIV) 25983 ethyl 2-(4-[2-[[(4-fluoroanilino)carbonyl](heptyl)amino]ethyl]phenoxy)-2-methylpropanoate C28H39FN2O4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(VIII)

In an alternative procedure, sodium 4-acetylbenzenesulfonate (IV) was refluxed with POCl3 and subsequently treated with dibenzylamine to afford sulfonamide (V). Bromination of (V) in chloroform yielded the bromo ketone (VI), which was hydrolyzed to phenacyl alcohol (VII) by treatment with ethanolic betaine, followed by aqueous NaHCO3. Addition of 4-fluorophenyl isocyanate (VIII) to (VII) and then cyclization in refluxing HOAc yielded the oxazolone (IX). Final debenzylation was achieved with concentrated H2SO4 to give the target sulfonamide.

1 Godessart, N.; Crespo, M.I.; Puig, C.; et al.; Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors. J Med Chem 2000, 43, 2, 214.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 44956 sodium 4-acetylbenzenesulfonate 61827-67-6 C8H7NaO4S 详情 详情
(V) 44957 4-acetyl-N,N-dibenzylbenzenesulfonamide C22H21NO3S 详情 详情
(VI) 44958 N,N-dibenzyl-4-(2-bromoacetyl)benzenesulfonamide C22H20BrNO3S 详情 详情
(VII) 44959 N,N-dibenzyl-4-glycoloylbenzenesulfonamide C22H21NO4S 详情 详情
(VIII) 17977 1-Fluoro-4-isocyanatobenzene; 4-Fluorophenyl isocyanate 1195-45-5 C7H4FNO 详情 详情
(IX) 44960 N,N-dibenzyl-4-[3-(4-fluorophenyl)-2-oxo-2,3-dihydro-1,3-oxazol-4-yl]benzenesulfonamide C29H23FN2O4S 详情 详情
Extended Information